Inhalation Anesthetics Market Size, Share, By Product Type (Sevoflurane, Desflurane, Isoflurane, and Others), Application (Induction and Maintenance), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035

Report Code: PMI398220 | Publish Date: June 2023 | No. of Pages: 155

Global Inhalation Anesthetics Market Market Companies

  • Baxter
  • AbbVie
  • Fresenius Kabi Canada Ltd.
  • Halocarbon, LLC
  • Piramal Critical Care
  • Lunan Pharmaceutical Group
  • Midmark Corporation
  • NYSORA
  • Sedana Medical AB
  • VERO Biotech
  • Troikaa
  • Merck KGaA
  • Dechra

 

Recent News:

  • Sentara Health officials announced the reduction of climate pollution from a greenhouse gas used for anesthesia, part of the system’s wider effort was to reduce health care’s sizable carbon footprint, in July 2024. The health system’s hospitals throughout Virginia and North Carolina had largely phased out the anesthetic gas called desflurane, which was the most potent greenhouse gas among inhaled anesthetics.
  • A team of scientists at the Max Planck Institute for Experimental Medicine in Göttingen had found that isoflurane, an inhaled anesthetic drug switched on an import pathway across the blood-brain barrier. Isoflurane supported chemotherapy of brain tumors in mice, in October 2021. This drug delivery system could be used to treat many diseases of the nervous system.

Inhalation Anesthetics Market Companies Forecast 2025-2035